Regular Meeting

6th Regular Meeting Kyoto Breast Cancer Consensus Conference (07/19/2009 Updated)

Finished

Theme: Breast Cancer Biomarker

"Individualized Medical Treatment by Preoperative Chemotherapy"

Date: Saturday 18th July 2009

Time: 15:30 - 18:30 ( Enrollments starts at 15:00-)

Venue: The Westin Miyako Hotel, Kyoto.  East Wing, 2nd Floor, 'Yamashiro no ma' Room  (Tel +81-75-771-7111)

Fee: JPY 3,000

 

Agenda

15:15-15:30    "Taxotel information"    Sanofi -Aventis


15:30-18:30

1. Opening address  Dr. Takahito Okamura 

Yamato Takada Municipal Hospital Surgery

2. The 6th questionnaire result report

Dr. Takayuki Ueno

                                        Kyoto University Hospital Breast Surgery Department

3. The present situation and prospect of Biomarker

             Dr. Takayuki Ueno

                                         Kyoto University Hospital Breast Surgery Department

4. Report of the current situation

                                        Chair: Dr. Yoshio Moriguchi  Kyoto City Hospital Surgery

       1) Dr. Masae Torii    Kitano Hospital Breast Surgery Department

       2) Dr. Hironori Kato  Kure Medical Center/Chugoku Cancer Center Surgery

       3) Dr. Norimichi Suga     Suga Norimichi Clinic / Hiei Hospital

       4) Dr. Nobuko Sakita / Dr. Shigeru Tsuyuki   Osaka Red Cross Hospital Surgery

5. Discussing  Breast Cancer Biomarker

     "Individualized Medical Treatment by Preoperative Chemotherapy"

   Moderator: Dr. Takayuki Ueno

                        Kyoto University Hospital Breast Surgery Department

                      

                        Dr. Yoshiki Mikami

                        Kyoto University Hospital Diagnostic Pathology Department

6. Closing address

                                   Dr. Takashi Inamoto   

                                   Kitano Hospital Breast Surgery Department

Co-hosted by: Kyoto Breast Cancer Consensus Conference

                             Ministry of Education, Culture, Sports, Science and Technology  

                             'Raising Proficient Oncologists'
                            

                             Sanofi-Aventis